Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-12-02 Sale | 2024-12-03 4:30 pm | Verve Therapeutics Inc. | VERV | Dorval Allison Chief Financial Officer | 555 | $5.64 | $3,130 | 7,255 (Direct) | View |
| 2024-06-13 Sale | 2024-06-17 7:18 pm | PUMA BIOTECHNOLOGY INC. | PBYI | Dorval Allison Director | 11,000 | $3.3724 | $37,096 | 33,000 (Direct) | View |
| 2023-11-29 Sale | 2023-12-01 4:30 pm | Verve Therapeutics Inc. | VERV | Dorval Allison Chief Financial Officer | 554 | $11.45 | $6,343 | 7,810 (Direct) | View |
| 2023-06-13 Sale | 2023-06-15 9:01 pm | PUMA BIOTECHNOLOGY INC. | PBYI | Dorval Allison Director | 10,000 | $3.45 | $34,500 | 44,000 (Direct) | View |
| 2022-11-29 Sale | 2022-12-01 5:00 pm | Verve Therapeutics Inc. | VERV | Dorval Allison Chief Financial Officer | 554 | $22.1 | $12,243 | 7,811 (Direct) | View |
| 2021-02-11 Sale | 2021-02-16 4:10 pm | Voyager Therapeutics Inc. | VYGR | Dorval Allison Chief Financial Officer | 3,186 | $7.55 | $24,054 | 45,894 (Direct) | View |
| 2021-01-12 Sale | 2021-01-14 5:57 pm | Voyager Therapeutics Inc. | VYGR | Dorval Allison Chief Financial Officer | 2,942 | $8.62 | $25,360 | 49,080 (Direct) | View |
| 2020-01-21 Sale | 2020-01-29 5:27 pm | Voyager Therapeutics Inc. | VYGR | Dorval Allison Chief Financial Officer | 3,128 | $13.36 | $41,790 | 24,522 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-11-29 Exercise | 2024-12-03 4:30 pm | N/A N/A | Verve Therapeutics Inc. | VERV | Dorval Allison Chief Financial Officer | 1,875 | $0 | 7,255 (Direct) | View |
| 2024-06-18 Option Award | 2024-06-21 9:17 pm | N/A N/A | PUMA BIOTECHNOLOGY INC. | PBYI | Dorval Allison Director | 27,000 | $0 | 60,000 (Direct) | View |
| 2024-06-05 Option Award | 2024-06-07 6:00 pm | N/A 2034-06-04 | Aerovate Therapeutics Inc. | AVTE | Dorval Allison Director | 12,500 | $0 | 12,500 (Direct) | View |
| 2024-02-14 Option Award | 2024-02-16 4:30 pm | N/A 2034-02-13 | Verve Therapeutics Inc. | VERV | Dorval Allison Chief Financial Officer | 225,000 | $0 | 225,000 (Direct) | View |
| 2023-11-29 Exercise | 2023-12-01 4:30 pm | N/A N/A | Verve Therapeutics Inc. | VERV | Dorval Allison Chief Financial Officer | 1,875 | $0 | 7,810 (Direct) | View |
| 2023-06-13 Option Award | 2023-06-15 9:01 pm | N/A N/A | PUMA BIOTECHNOLOGY INC. | PBYI | Dorval Allison Director | 27,000 | $0 | 44,000 (Direct) | View |
| 2023-06-06 Option Award | 2023-06-08 6:00 pm | N/A 2033-06-05 | Aerovate Therapeutics Inc. | AVTE | Dorval Allison Director | 12,500 | $0 | 12,500 (Direct) | View |
| 2023-02-14 Option Award | 2023-02-16 5:00 pm | N/A 2033-02-13 | Verve Therapeutics Inc. | VERV | Dorval Allison Chief Financial Officer | 182,800 | $0 | 182,800 (Direct) | View |
| 2022-11-29 Exercise | 2022-12-01 5:00 pm | N/A N/A | Verve Therapeutics Inc. | VERV | Dorval Allison Chief Financial Officer | 1,875 | $0 | 7,811 (Direct) | View |
| 2022-06-21 Option Award | 2022-06-22 5:01 pm | N/A 2032-06-20 | Aerovate Therapeutics Inc. | AVTE | Dorval Allison Director | 12,500 | $0 | 12,500 (Direct) | View |
| 2022-06-14 Option Award | 2022-06-17 4:16 pm | N/A N/A | PUMA BIOTECHNOLOGY INC. | PBYI | Dorval Allison Director | 27,000 | $0 | 27,000 (Direct) | View |
| 2022-02-11 Option Award | 2022-02-15 09:00 am | N/A 2032-02-10 | Verve Therapeutics Inc. | VERV | Dorval Allison Chief Financial Officer | 60,000 | $0 | 60,000 (Direct) | View |
| 2021-11-29 Option Award | 2021-11-30 4:26 pm | N/A 2031-11-28 | Verve Therapeutics Inc. | VERV | Dorval Allison Chief Financial Officer | 142,500 | $0 | 142,500 (Direct) | View |
| 2021-07-15 Option Award | 2021-07-19 4:28 pm | N/A 2031-07-14 | Aerovate Therapeutics Inc. | AVTE | Dorval Allison Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2021-07-15 Option Award | 2021-07-16 4:46 pm | N/A 2031-07-14 | PUMA BIOTECHNOLOGY INC. | PBYI | Dorval Allison Director | 108,721 | $0 | 108,721 (Direct) | View |
| 2021-03-19 Option Award | 2021-03-23 4:10 pm | N/A N/A | Voyager Therapeutics Inc. | VYGR | Dorval Allison Chief Financial Officer | 30,000 | $0 | 109,894 (Direct) | View |
| 2021-02-16 Option Award | 2021-02-18 4:55 pm | N/A 2031-02-16 | Voyager Therapeutics Inc. | VYGR | Dorval Allison Chief Financial Officer | 102,000 | $0 | 147,894 (Direct) | View |
| 2020-02-10 Option Award | 2020-02-12 6:21 pm | N/A 2030-02-10 | Voyager Therapeutics Inc. | VYGR | Dorval Allison Chief Financial Officer | 82,500 | $0 | 107,022 (Direct) | View |